Xeloda is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Xeloda is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Xeloda is a fluoropyrimidine carbamate with antineoplastic activity indicated for the treatment of metastatic breast cancer and colon cancer. It is an orally administered systemic prodrug that has little pharmacologic activity until it is converted to fluorouracil by enzymes that are expressed in higher concentrations in many tumors. Fluorouracil it then metabolized both normal and tumor cells to 5-fluoro-2′-deoxyuridine 5′-monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP).
Imprints
Drug: Xeloda
Strength: 500 Mg
Pill Imprint: XELODA 500
Color: Pink
Shape: Elliptical / Oval
View Images & Details
Drug: Xeloda
Strength: 150 Mg
Pill Imprint: XELODA 150
Color: Pink
Shape: Elliptical / Oval
View Images & Details